铁亡的分子代码:在肝脏疾病中出现的多维修饰和治疗点
Xiaotong Cai1, Yinhao Zhang1, Wenqing Qin2
1School of Life Sciences, Beijing University of Chinese Medicine, Beijing, 100029, China.
Metabolism: clinical and experimental
|November 28, 2025
概括
铁灭,细胞死亡过程,是肝脏疾病和癌症的关键. 表观遗传和翻译后修改调节铁,为肝脏疾病提供新的治疗点.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 病理学 病理学 病理学
背景情况:
- 铁,一种依赖铁的细胞死亡,以脂质过氧化为标志,显著影响肝脏疾病的发病性.
- 它在慢性肝脏疾病中导致肝细胞损伤,并在肝细胞癌中呈现治疗标.
研究的目的:
- 综合审查铁灭的调节网络,重点关注表观遗传和后翻译性修改.
- 分析这些修改如何影响与铁灭相关的分子及其在肝脏疾病中的作用.
主要方法:
- 对肝脏疾病中铁亡调节现有文献的综述.
- 对表观遗传修饰 (DNA/RNA甲基化,非编码RNA,基因素乙化) 和翻译后修饰的分析.
- 对GPX4,SLC7A11,ACSL4和TFR1.1.等关键铁灭调节者的检查.
主要成果:
- 表观遗传和翻译后修改动态控制铁灭调节者的表达,稳定性和活性.
- 这些修改可以促进或抑制铁亡,这取决于具体的背景和疾病阶段.
- 针对铁亡途径的治疗干预措施在临床前模型中显示出希望,但面临临临床翻译挑战.
结论:
- 铁亡是肝脏病理学中的一个动态和可针对性的治疗过程.
- 了解监管修改的复杂性对于制定有效的疾病干预策略至关重要.
- 针对这些修改提供了一种精细的方法来管理肝脏疾病和癌症.
相关概念视频
Translation
155.0K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
155.0K
Translation
17.4K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
17.4K
Covalently Linked Protein Regulators
8.6K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
8.6K
Necrosis
6.2K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.2K
Gene Families
9.7K
Gene families consist of groups of genes proposed to have originated from a common ancestor. Typically these arise through events in which a gene or genes are mistakenly duplicated during cell division. Unlike their parent genes (which are subject to selection pressure to maintain function), these gene copies do not need to preserve their sequences and may evolve at a relatively faster rate.
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
9.7K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
203
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
203

